- Article metrics
- Last updated: Wed, 3 Jun 2026 8:57:40 Z
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Access & Citations
-
- 20k
- Article Accesses
-
- 40
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 19 tweeters
- 4 blogs
- 118 news outlets
- 1 Redditors
- 1 Wikipedia page
- 40 Mendeley
This article is in the 99th percentile (ranked 765th) of the 429,378 tracked articles of a similar age in all journals and the 99th percentile (ranked 17th) of the 2,293 tracked articles of a similar age in Nature Communications
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
MiNK Therapeutics’ AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress
Drug Development & Delivery -
Critical Care Evidence Updates – February 2024
The Bottom Line -
HMN 2024: COVID caused cancer tumours to shrink in mice – new study
Health Medicine Network -
HMN 2024: COVID caused cancer tumors to shrink in mice—new study
Health Medicine Network
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.